Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · TRADEGATE · EUR · DE

F6T:TRADEGATE is the listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. The company is engaged in advancing its innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of approximately $280.9 million, Fate Therapeutics continues to make strides in its field, reflecting its commitment to addressing significant medical needs. Recent news and filings may provide further insights into the company's ongoing projects and market activities.